Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Power List / 2026 / Honorees / Power List Honorees / Eric Donnenfeld

Eric Donnenfeld

Clinical Professor of Ophthalmology New York University; Trustee Dartmouth Medical School, USA

  • Profile

About Eric Donnenfeld

Eric Donnenfeld is the founder and managing partner of Ophthalmic Consultants of Long Island, which has grown into five states. Over the past year he has served as President of the International Intraocular Implant Society (IIIC) and chaired a retreat in New York City of many of the most influential cataract surgeons in the world. He is also a trustee of Dartmouth Medical School and a Clinical Professor of Ophthalmology at New York University. He is one of the busiest surgeons in the northeast of the United States, and performs complex cataract surgery and anterior segment reconstruction, laser vision correction, corneal transplantation and ocular surface disease management.

Over the past year he has also been an FDA investigator for two multifocal IOLs, two extended depth of focus IOLs, cell therapy for corneal endothelial decompensation, and two pharmaceuticals for dry eye. He has published nine peer review publications in the last 18 months and has lectured on five continents. He is on the board of five ophthalmic companies and consults with 50 ophthalmology companies. Donnenfeld continues to be dedicated to teaching and is director of his anterior segment fellowship. He is an active member of ASCRS, AAO, ESCRS, AECOS, Cedars-Aspen, and the IIIC. He is passionate about improving vision, advancing technology, and improving quality of life.

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: